Prevention of induced colitis in mice by the Ras antagonist farnesylthiosalicylic acid

Digestive Diseases and Sciences

Volumn 57, Issue 2, 2012, Pages 320-326

  Oron, Tal ^a   Elad Sfadia, Galit ^c   Haklai, Roni ^c   Aizman, Elizabeta ^c   Brazowski, Eli ^b   Kloog, Yoel ^c   Reif, Shimon ^a,b  

^a Dana Children's Hospital   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colitis; Farnesythiosalicylic acid (FTS); Prevention; Ras

Indexed keywords

INTERLEUKIN 1BETA; MYELOPEROXIDASE; RAS PROTEIN; SALIRASIB; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG SCREENING; EFFECTOR CELL; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN;

EID: 84856755700     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1880-y     Document Type: Article

References (34)

1. DK Podolsky 2002 Inflammatory bowel disease N Engl J Med 347 417 429 12167685 10.1056/NEJMra020831 1:CAS:528:DC%2BD38XlvFKrt7s%3D (Pubitemid 34851835)
2. F Shanahn 2001 Inflammatory bowel disease: Immunodiagnostics, immunotheraputics, and ecotherapeutics Gastroenterology 120 622 635 10.1053/gast.2001.22122
3. C Fiocchi 1998 Inflammatory bowel disease: Etiology and pathogenesis Gastroenterology 115 182 205 9649475 10.1016/S0016-5085(98)70381-6 1:STN:280:DyaK1czitlGjtg%3D%3D (Pubitemid 28307304)
4. GM Bokoch CJ Der 1993 Emerging concepts in the Ras superfamily of GTP-binding proteins FASEB J 7 750 759 8330683 1:CAS:528:DyaK3sXltlemurc%3D (Pubitemid 23199533)
5. GW Reuther CJ Der 2000 The Ras branch of small GTPases: Ras family members don't fall far from the tree Curr Opin Cell Biol 12 157 165 10712923 10.1016/S0955-0674(99)00071-X 1:CAS:528:DC%2BD3cXitVantL0%3D (Pubitemid 30142561)
6. K Scheffzek MR Ahmadian W Kabsch, et al. 1997 The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants Science 277 333 338 9219684 10.1126/science.277.5324.333 1:CAS:528: DyaK2sXkvVelsr8%3D (Pubitemid 27450699)
7. M Kafri Y Kloog AD Korczyn, et al. 2005 Inhibition of Ras attenuates the course of experimental autoimmune neuritis J Neuroimmunol 168 46 55 16154640 10.1016/j.jneuroim.2005.07.008 1:CAS:528:DC%2BD2MXhtVynt7bP (Pubitemid 41398186)
8. HC Clarke HM Kocher A Khwaja, et al. 2003 Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis J Am Soc Nephrol 14 848 854 12660318 10.1097/01.ASN.0000057543.55318.8B 1:CAS:528:DC%2BD3sXitF2jurs%3D (Pubitemid 36359266)
9. A Katzav Y Kloog AD Korczyn, et al. 2001 Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor FTS Clin Exp Immunol 126 570 577 11737078 10.1046/j.1365-2249.2001.01674.x 1:CAS:528:DC%2BD38XltVegsw%3D%3D (Pubitemid 34008734)
10. S Weijzen MP Velders WM Kast 1999 Modulation of the immune response and tumor growth by activated Ras Leukemia 13 502 513 10214854 10.1038/sj.leu. 2401367 1:CAS:528:DyaK1MXivFSktLw%3D (Pubitemid 29195276)
11. Haklai R, Weisz MG, Elad G, et al. Dislodgment and accelerated degradation of Ras. Biochemistry. 1998;37:1306-1314.
12. M Marom R Haklai G Ben-Baruch, et al. 1995 Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid J Biol Chem 270 2263 2270
13. G Elad-Sfadia R Haklai E Ballan, et al. 2002 Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase J Biol Chem 277 37169 37175 12149263 10.1074/jbc.M205698200 1:CAS:528:DC%2BD38XnsVaqtbs%3D
14. G Elad-Sfadia R Haklai E Balan, et al. 2004 Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase J Biol Chem 279 34822 34930 10.1074/jbc.M312697200 (Pubitemid 39318128)
15. L Belanis J Sarah SJ Plowman, et al. 2008 Galectin-1 is a novel structural component and a major regulator of H-Ras nanoclusters Mol Biol Cell 19 1404 1414 18234837 10.1091/mbc.E07-10-1053 1:CAS:528:DC%2BD1cXlslemt7Y%3D (Pubitemid 351805095)
16. Shalom-Feuerstein R, Levy R, Makovski V, et al. Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras. Biochim Biophys Acta. 2008;1783:985-993.
17. Y Kloog AD Cox 2000 RAS inhibitors: potential for cancer therapeutics Mol Med Today 6 398 402 11006529 10.1016/S1357-4310(00)01789-5 1:CAS:528: DC%2BD3cXmslKlsLs%3D
18. DT Le KM Shannon 2002 Ras processing as a therapeutic target in hematologic malignancies Curr Opin Hematol 9 308 315 12042705 10.1097/00062752-200207000-00008 (Pubitemid 34596875)
19. S Reif H Aeed Y Shilo, et al. 2004 Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid J Hepatol 41 235 241 15288472 10.1016/j.jhep.2004.04.010 1:CAS:528:DC%2BD2cXmt1KjsL8%3D (Pubitemid 39177627)
20. S Reif B Weis H Aeed, et al. 1999 The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats J Hepatol 31 1053 1061 10604579 10.1016/S0168-8278(99)80318-3 1:CAS:528:DC%2BD3cXhtlKmsw%3D%3D
21. D Marciano G Ben-Bar M Marom, et al. 1995 Farnesyl derivatives of rigid carboxylic acid-inhibitors of Ras dependent cell growth J Med Chem 38 1267 1272 7731012 10.1021/jm00008a004 1:CAS:528:DyaK2MXkvVWruro%3D
22. A Paz R Haklai G Elad, et al. 2000 Galectin-1 binds H-Ras to mediate Ras membrane anchorage and cell transformation Oncogene 20 471 474
23. D Rachmilewitz F Karmeli K Takabayashi, et al. 2002 Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis Gastroenterology 122 1428 1441 11984528 10.1053/gast.2002.32994 1:CAS:528:DC%2BD38Xkt1Cru7c%3D (Pubitemid 34465184)
24. PP Bradley DA Priebat RD Christensen, et al. 1982 Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 206 209 6276474 10.1111/1523-1747.ep12506462 1:CAS:528:DyaL38XotlyitQ%3D%3D (Pubitemid 12171880)
25. P Sharon M Ligumsky D Rachmilewitz, et al. 1978 Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine Gastroenterology 75 638 640 30669 1:CAS:528:DyaE1cXlvFGjsbg%3D (Pubitemid 9025499)
26. D Karussis O Abramsky N Grigoriadis, et al. 2000 The Ras-pathway inhibitor S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis J Neuroimmunol 120 1 9 10.1016/S0165-5728(01)00385-X (Pubitemid 33016718)
27. I Zvibel D Bar-Zohar Y Kloog, et al. 2008 The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells Dig Dis Sci 53 1048 1053 17934818 10.1007/s10620-007- 9984-0 1:CAS:528:DC%2BD1cXjt1WitLs%3D (Pubitemid 351379847)
28. JB Olivera N Biedere JE Niemela, et al. 2007 NRAS mutation causes a human autoimmune lymphoproliferative syndrome Proc Natl Acad Sci USA 104 8953 8958 10.1073/pnas.0702975104 (Pubitemid 47175418)
29. PE Fields TF Gajewski 2000 Biochemical analysis of activated T lymphocytes. Protein phosphorylation and Ras, ERK, and JNK activation Methods Mol Biol 134 307 317 10730269 1:CAS:528:DC%2BD3cXps1Omuw%3D%3D
30. E Genot DA Cantrell 2000 Ras regulation and function in lymphocytes Curr Opin Immunol 12 289 294 10781411 10.1016/S0952-7915(00)00089-3 1:CAS:528:DC%2BD3cXjsFeqsbw%3D (Pubitemid 30240538)
31. A Mor G Keren Y Kloog, et al. 2008 N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells Eur J Immunol 38 1493 1502 18461565 10.1002/eji.200838292 1:CAS:528:DC%2BD1cXnsF2hurw%3D
32. RE Marks AW Ho C Robbel, et al. 2007 Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level Blood 110 1982 1988 17545504 10.1182/blood-2006-06-031088 1:CAS:528:DC%2BD2sXhtVGjtbjM (Pubitemid 47443912)
33. A Mor Y Kloog G Keren, et al. 2009 Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice Eur J Pharmacol 616 301 305 19527709 10.1016/j.ejphar.2009.06.001 1:CAS:528:DC%2BD1MXptlansbc%3D
34. D Rachmilewitz K Katakura F Karmeli, et al. 2004 Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis Gastroenterology 126 520 528 14762789 10.1053/j.gastro. 2003.11.019 1:CAS:528:DC%2BD2cXhvV2rtrw%3D (Pubitemid 38182309)